Day

May 25, 2017
This latest report is a study published in the British Journal of Haematology comparing whole-body ultra-low dose CT (WBULDCT) with spinal MRI (SMRI) in the assessment of disease in multiple myeloma. ‘Diagnostic value of whole-body ultra-low dose computed tomography in comparison with spinal magnetic resonance imaging in the assessment of disease in multiple myeloma’¬†focuses on...
Continue Reading
Multiple Myeloma
About 400 New Zealanders a year are diagnosed with the blood cancer multiple myeloma, and the number is rising. A malignancy of the plasma cell, it led to destruction of the body’s defence mechanisms, and was the second most common blood cancer being treated in this country, after Non-Hodgkin’s lymphoma. Survival with the cancer had...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand